Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
January 07, 2014
FDA Reclassifies ECP Devices for Refractory Angina as Class II
Vasomedical Inc. announced that the FDA issued its final order Dec. 30, 2013, reclassifying external counterpulsation (...
April 13, 2010
Combined Holter Records Both ECG, Blood Pressure
April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter...
April 10, 2009
Vasomedical Introduces BIOX Holter Monitor, Analysis Software
April 10, 2009 - Vasomedical Inc. this week said it received FDA 510(k) clearance to market Vasomedical-BIOX 1305 ECG...
April 02, 2009
Results of Two Studies on Counterpulsation Therapy to Promote Collateral Growth Presented at the ACC
April 2, 2009 - Vasomedical Inc. this week conducted two presentations on the beneficial effects of EECP external...
January 24, 2008
Medicare Increases Rates for Vasomedical EECP Therapy for 2008
January 25, 2008 - Medicare has increased reimbursement payment rates for EECP therapy for 2008, effective immediatel
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions